Tellgen Corporation (SHE:300642)
China · Delayed Price · Currency is CNY 17.32
-1.01 (-5.51%)
Sep 4, 2026, 3:04 PM CST
Tellgen Revenue
Tellgen had revenue of 104.73M CNY in the quarter ending June 30, 2026, with 24.44% growth. This brings the company's revenue in the last twelve months to 392.11M, up 3.14% year-over-year. In the year 2025, Tellgen had annual revenue of 363.83M, down -16.70%.
Revenue (ttm)
392.11M
Revenue Growth
+3.14%
P/S Ratio
7.06
Revenue / Employee
574.10K
Employees
683
Market Cap
2.77B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 363.83M | -72.95M | -16.70% |
| Dec 31, 2024 | 436.78M | -106.03M | -19.53% |
| Dec 31, 2023 | 542.81M | -173.16M | -24.19% |
| Jan 1, 2023 | 715.97M | 61.38M | 9.38% |
| Dec 31, 2021 | 654.59M | 165.01M | 33.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.69B |
| Ningbo David Medical Device | 584.68M |
| Chison Medical Technologies | 441.10M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Jiangsu Canopus Wisdom Medical Technology | 384.50M |
| Nanjing Medlander Medical Technology | 383.30M |
| CareRay Digital Medical Technology | 319.79M |
| Beijing Leadman Biochemistry | 317.79M |